|
A61P 1/00
|
Drugs for disorders of the alimentary tract or the digestive system |
|
A61P 1/02
|
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis |
|
A61P 1/04
|
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants |
|
A61P 1/06
|
Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia |
|
A61P 1/08
|
Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics |
|
A61P 1/10
|
Laxatives |
|
A61P 1/12
|
Antidiarrhoeals |
|
A61P 1/14
|
Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents |
|
A61P 1/16
|
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics |
|
A61P 1/18
|
Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes |
|
A61P 3/00
|
Drugs for disorders of the metabolism |
|
A61P 3/02
|
Nutrients, e.g. vitamins, minerals |
|
A61P 3/04
|
Anorexiants; Antiobesity agents |
|
A61P 3/06
|
Antihyperlipidemics |
|
A61P 3/08
|
Drugs for disorders of the metabolism for glucose homeostasis |
|
A61P 3/10
|
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics |
|
A61P 3/12
|
Drugs for disorders of the metabolism for electrolyte homeostasis |
|
A61P 3/14
|
Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis |
|
A61P 5/00
|
Drugs for disorders of the endocrine system |
|
A61P 5/02
|
Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin |
|
A61P 5/04
|
Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones |
|
A61P 5/06
|
Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH |
|
A61P 5/08
|
Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones |
|
A61P 5/10
|
Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH |
|
A61P 5/12
|
Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones |
|
A61P 5/14
|
Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 |
|
A61P 5/16
|
Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones |
|
A61P 5/18
|
Drugs for disorders of the endocrine system of the parathyroid hormones |
|
A61P 5/20
|
Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH |
|
A61P 5/22
|
Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin |
|
A61P 5/24
|
Drugs for disorders of the endocrine system of the sex hormones |
|
A61P 5/26
|
Androgens |
|
A61P 5/28
|
Antiandrogens |
|
A61P 5/30
|
Oestrogens |
|
A61P 5/32
|
Antioestrogens |
|
A61P 5/34
|
Gestagens |
|
A61P 5/36
|
Antigestagens |
|
A61P 5/38
|
Drugs for disorders of the endocrine system of the suprarenal hormones |
|
A61P 5/40
|
Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids |
|
A61P 5/42
|
Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids |
|
A61P 5/44
|
Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids |
|
A61P 5/46
|
Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids |
|
A61P 5/48
|
Drugs for disorders of the endocrine system of the pancreatic hormones |
|
A61P 5/50
|
Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin |
|
A61P 7/00
|
Drugs for disorders of the blood or the extracellular fluid |
|
A61P 7/02
|
Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors |
|
A61P 7/04
|
Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents |
|
A61P 7/06
|
Antianaemics |
|
A61P 7/08
|
Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock |
|
A61P 7/10
|
Antioedematous agents; Diuretics |
|
A61P 7/12
|
Antidiuretics, e.g. drugs for diabetes insipidus |
|
A61P 9/00
|
Drugs for disorders of the cardiovascular system |
|
A61P 9/02
|
Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives |
|
A61P 9/04
|
Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure |
|
A61P 9/06
|
Antiarrhythmics |
|
A61P 9/08
|
Vasodilators for multiple indications |
|
A61P 9/10
|
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis |
|
A61P 9/12
|
Antihypertensives |
|
A61P 9/14
|
Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers |
|
A61P 11/00
|
Drugs for disorders of the respiratory system |
|
A61P 11/02
|
Nasal agents, e.g. decongestants |
|
A61P 11/04
|
Drugs for disorders of the respiratory system for throat disorders |
|
A61P 11/06
|
Antiasthmatics |
|
A61P 11/08
|
Bronchodilators |
|
A61P 11/10
|
Expectorants |
|
A61P 11/12
|
Mucolytics |
|
A61P 11/14
|
Antitussive agents |
|
A61P 11/16
|
Central respiratory analeptics |
|
A61P 13/00
|
Drugs for disorders of the urinary system |
|
A61P 13/02
|
Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers |
|
A61P 13/04
|
Drugs for disorders of the urinary system for urolithiasis |
|
A61P 13/06
|
Anti-spasmodics |
|
A61P 13/08
|
Drugs for disorders of the urinary system of the prostate |
|
A61P 13/10
|
Drugs for disorders of the urinary system of the bladder |
|
A61P 13/12
|
Drugs for disorders of the urinary system of the kidneys |
|
A61P 15/00
|
Drugs for genital or sexual disorders; Contraceptives |
|
A61P 15/02
|
Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina |
|
A61P 15/04
|
Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics |
|
A61P 15/06
|
Antiabortive agents; Labour repressants |
|
A61P 15/08
|
Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis |
|
A61P 15/10
|
Drugs for genital or sexual disorders; Contraceptives for impotence |
|
A61P 15/12
|
Drugs for genital or sexual disorders; Contraceptives for climacteric disorders |
|
A61P 15/14
|
Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea |
|
A61P 15/16
|
Masculine contraceptives |
|
A61P 15/18
|
Feminine contraceptives |
|
A61P 17/00
|
Drugs for dermatological disorders |
|
A61P 17/02
|
Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like |
|
A61P 17/04
|
Antipruritics |
|
A61P 17/06
|
Antipsoriatics |
|
A61P 17/08
|
Antiseborrheics |
|
A61P 17/10
|
Anti-acne agents |
|
A61P 17/12
|
Keratolytics, e.g. wart or anti-corn preparations |
|
A61P 17/14
|
Drugs for dermatological disorders for baldness or alopecia |
|
A61P 17/16
|
Emollients or protectives, e.g. against radiation |
|
A61P 17/18
|
Antioxidants, e.g. antiradicals |
|
A61P 19/00
|
Drugs for skeletal disorders |
|
A61P 19/02
|
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis |
|
A61P 19/04
|
Drugs for skeletal disorders for non-specific disorders of the connective tissue |
|
A61P 19/06
|
Antigout agents, e.g. antihyperuricemic or uricosuric agents |
|
A61P 19/08
|
Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease |
|
A61P 19/10
|
Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis |
|
A61P 21/00
|
Drugs for disorders of the muscular or neuromuscular system |
|
A61P 21/02
|
Muscle relaxants, e.g. for tetanus or cramps |
|
A61P 21/04
|
Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis |
|
A61P 21/06
|
Anabolic agents |
|
A61P 23/00
|
Anaesthetics |
|
A61P 23/02
|
Local anaesthetics |
|
A61P 25/00
|
Drugs for disorders of the nervous system |
|
A61P 25/02
|
Drugs for disorders of the nervous system for peripheral neuropathies |
|
A61P 25/04
|
Centrally acting analgesics, e.g. opioids |
|
A61P 25/06
|
Antimigraine agents |
|
A61P 25/08
|
Antiepileptics; Anticonvulsants |
|
A61P 25/10
|
Antiepileptics; Anticonvulsants for petit-mal |
|
A61P 25/12
|
Antiepileptics; Anticonvulsants for grand-mal |
|
A61P 25/14
|
Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia |
|
A61P 25/16
|
Anti-Parkinson drugs |
|
A61P 25/18
|
Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia |
|
A61P 25/20
|
Hypnotics; Sedatives |
|
A61P 25/22
|
Anxiolytics |
|
A61P 25/24
|
Antidepressants |
|
A61P 25/26
|
Psychostimulants, e.g. nicotine, cocaine |
|
A61P 25/28
|
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia |
|
A61P 25/30
|
Drugs for disorders of the nervous system for treating abuse or dependence |
|
A61P 25/32
|
Alcohol-abuse |
|
A61P 25/34
|
Tobacco-abuse |
|
A61P 25/36
|
Opioid-abuse |
|
A61P 27/00
|
Drugs for disorders of the senses |
|
A61P 27/02
|
Ophthalmic agents |
|
A61P 27/04
|
Artificial tears; Irrigation solutions |
|
A61P 27/06
|
Antiglaucoma agents or miotics |
|
A61P 27/08
|
Mydriatics or cycloplegics |
|
A61P 27/10
|
Ophthalmic agents for accommodation disorders, e.g. myopia |
|
A61P 27/12
|
Ophthalmic agents for cataracts |
|
A61P 27/14
|
Decongestants or antiallergics |
|
A61P 27/16
|
Otologicals |
|
A61P 29/00
|
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] |
|
A61P 29/02
|
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect |
|
A61P 31/00
|
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics |
|
A61P 31/02
|
Local antiseptics |
|
A61P 31/04
|
Antibacterial agents |
|
A61P 31/06
|
Antibacterial agents for tuberculosis |
|
A61P 31/08
|
Antibacterial agents for leprosy |
|
A61P 31/10
|
Antimycotics |
|
A61P 31/12
|
Antivirals |
|
A61P 31/14
|
Antivirals for RNA viruses |
|
A61P 31/16
|
Antivirals for RNA viruses for influenza or rhinoviruses |
|
A61P 31/18
|
Antivirals for RNA viruses for HIV |
|
A61P 31/20
|
Antivirals for DNA viruses |
|
A61P 31/22
|
Antivirals for DNA viruses for herpes viruses |
|
A61P 33/00
|
Antiparasitic agents |
|
A61P 33/02
|
Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis |
|
A61P 33/04
|
Amoebicides |
|
A61P 33/06
|
Antimalarials |
|
A61P 33/08
|
Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii |
|
A61P 33/10
|
Anthelmintics |
|
A61P 33/12
|
Schistosomicides |
|
A61P 33/14
|
Ectoparasiticides, e.g. scabicides |
|
A61P 35/00
|
Antineoplastic agents |
|
A61P 35/02
|
Antineoplastic agents specific for leukemia |
|
A61P 35/04
|
Antineoplastic agents specific for metastasis |
|
A61P 37/00
|
Drugs for immunological or allergic disorders |
|
A61P 37/02
|
Immunomodulators |
|
A61P 37/04
|
Immunostimulants |
|
A61P 37/06
|
Immunosuppressants, e.g. drugs for graft rejection |
|
A61P 37/08
|
Antiallergic agents |
|
A61P 39/00
|
General protective or antinoxious agents |
|
A61P 39/02
|
Antidotes |
|
A61P 39/04
|
Chelating agents |
|
A61P 39/06
|
Free radical scavengers or antioxidants |
|
A61P 41/00
|
Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution |
|
A61P 43/00
|
Drugs for specific purposes, not provided for in groups |
